Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help
Search by PDB author
7DHA
DownloadVisualize
BU of 7dha by Molmil
crystal structure of CD38 in complex with daratumumab
Descriptor: ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1, Heavy Chain, Light chain
Authors:Lee, H.T, Heo, Y.S.
Deposit date:2020-11-13
Release date:2021-09-22
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (2.55 Å)
Cite:Crystal structure of CD38 in complex with daratumumab, a first-in-class anti-CD38 antibody drug for treating multiple myeloma.
Biochem.Biophys.Res.Commun., 536, 2021
7EOW
DownloadVisualize
BU of 7eow by Molmil
High-resolution structure of vWF A1 domain in complex with caplacizumab, the first nanobody-based medicine
Descriptor: caplacizumab, von Willebrand factor
Authors:Lee, H.T, Heo, Y.-S.
Deposit date:2021-04-23
Release date:2021-07-07
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (1.6 Å)
Cite:High-resolution structure of the vWF A1 domain in complex with caplacizumab, the first nanobody-based medicine for treating acquired TTP.
Biochem.Biophys.Res.Commun., 567, 2021
5X8M
DownloadVisualize
BU of 5x8m by Molmil
PD-L1 in complex with durvalumab
Descriptor: Programmed cell death 1 ligand 1, durvalumab heavy chain, durvalumab light chain
Authors:Heo, Y.S, Lee, H.T.
Deposit date:2017-03-03
Release date:2017-08-16
Method:X-RAY DIFFRACTION (2.661 Å)
Cite:Molecular mechanism of PD-1/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab
Sci Rep, 7, 2017
5X8L
DownloadVisualize
BU of 5x8l by Molmil
PD-L1 in complex with atezolizumab
Descriptor: Programmed cell death 1 ligand 1, atezolizumab heavy chain, atezolizumab light chain
Authors:Heo, Y.S, Lee, H.T.
Deposit date:2017-03-03
Release date:2017-08-16
Method:X-RAY DIFFRACTION (3.1 Å)
Cite:Molecular mechanism of PD-1/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab
Sci Rep, 7, 2017
7BXA
DownloadVisualize
BU of 7bxa by Molmil
Crystal structure of PD-1 in complex with tislelizumab Fab
Descriptor: Programmed cell death protein 1, heavy chain, light chain
Authors:Heo, Y.S, Lee, S.H, Lim, H, Lee, H.T, Kim, Y.J, Park, E.B.
Deposit date:2020-04-18
Release date:2020-06-10
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (3.32 Å)
Cite:Crystal structure of PD-1 in complex with an antibody-drug tislelizumab used in tumor immune checkpoint therapy.
Biochem.Biophys.Res.Commun., 527, 2020
3JBJ
DownloadVisualize
BU of 3jbj by Molmil
Cryo-EM reconstruction of F-actin
Descriptor: ADENOSINE-5'-DIPHOSPHATE, Actin, alpha skeletal muscle, ...
Authors:Kim, L.Y, Thompson, P.M, Lee, H.T, Pershad, M, Campbell, S.L, Alushin, G.M.
Deposit date:2015-09-03
Release date:2015-11-04
Last modified:2024-02-21
Method:ELECTRON MICROSCOPY (7.6 Å)
Cite:The Structural Basis of Actin Organization by Vinculin and Metavinculin.
J.Mol.Biol., 428, 2016
3JBK
DownloadVisualize
BU of 3jbk by Molmil
Cryo-EM reconstruction of the metavinculin-actin interface
Descriptor: ADENOSINE-5'-DIPHOSPHATE, Actin, alpha skeletal muscle, ...
Authors:Kim, L.Y, Thompson, P.M, Lee, H.T, Pershad, M, Campbell, S.L, Alushin, G.M.
Deposit date:2015-09-03
Release date:2015-11-04
Last modified:2024-02-21
Method:ELECTRON MICROSCOPY (8.2 Å)
Cite:The Structural Basis of Actin Organization by Vinculin and Metavinculin.
J.Mol.Biol., 428, 2016
3JBI
DownloadVisualize
BU of 3jbi by Molmil
MDFF model of the vinculin tail domain bound to F-actin
Descriptor: ADENOSINE-5'-DIPHOSPHATE, Actin, alpha skeletal muscle, ...
Authors:Kim, L.Y, Thompson, P.M, Lee, H.T, Pershad, M, Campbell, S.L, Alushin, G.M.
Deposit date:2015-09-02
Release date:2015-11-04
Last modified:2024-02-21
Method:ELECTRON MICROSCOPY (8.5 Å)
Cite:The Structural Basis of Actin Organization by Vinculin and Metavinculin.
J.Mol.Biol., 428, 2016
1ZOI
DownloadVisualize
BU of 1zoi by Molmil
Crystal Structure of a Stereoselective Esterase from Pseudomonas putida IFO12996
Descriptor: esterase
Authors:Elmi, F, Lee, H.T, Huang, J.Y, Hsieh, Y.C, Wang, Y.L, Chen, Y.J, Shaw, S.Y, Chen, C.J.
Deposit date:2005-05-13
Release date:2006-05-02
Last modified:2024-03-13
Method:X-RAY DIFFRACTION (1.6 Å)
Cite:Stereoselective esterase from Pseudomonas putida IFO12996 reveals alpha/beta hydrolase folds for D-beta-acetylthioisobutyric acid synthesis
J.Bacteriol., 187, 2005
7WWP
DownloadVisualize
BU of 7wwp by Molmil
Crystal structure of human Npl4
Descriptor: Nuclear protein localization protein 4 homolog, ZINC ION
Authors:Nguyen, T.Q, Le, L.T.M, Kim, D.H, Ko, K.S, Lee, H.T, Nguyen, Y.T.K, Kim, H.S, Han, B.W, Kang, W, Yang, J.K.
Deposit date:2022-02-14
Release date:2022-09-21
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (2.99 Å)
Cite:Structural basis for the interaction between human Npl4 and Npl4-binding motif of human Ufd1.
Structure, 30, 2022
7WWQ
DownloadVisualize
BU of 7wwq by Molmil
Crystal structure of human Ufd1-Npl4 complex
Descriptor: Nuclear protein localization protein 4 homolog, Ubiquitin recognition factor in ER-associated degradation protein 1
Authors:Nguyen, T.Q, Le, L.T.M, Kim, D.H, Ko, K.S, Lee, H.T, Nguyen, Y.T.K, Kim, H.S, Han, B.W, Kang, W, Yang, J.K.
Deposit date:2022-02-14
Release date:2022-09-21
Last modified:2022-11-16
Method:X-RAY DIFFRACTION (2.72 Å)
Cite:Structural basis for the interaction between human Npl4 and Npl4-binding motif of human Ufd1.
Structure, 30, 2022
6JC2
DownloadVisualize
BU of 6jc2 by Molmil
Crystal structure of the Fab fragment of ipilimumab
Descriptor: SULFATE ION, ipilimumab fab heavy chain, ipilimumab fab light chain
Authors:Heo, Y.S.
Deposit date:2019-01-27
Release date:2019-09-11
Method:X-RAY DIFFRACTION (2.65 Å)
Cite:Crystal Structure of the Fab Fragment of an Anti-CTLA-4 Antibody, Ipilimumab, Used for Cancer Immunotherapy
Bull.Korean Chem.Soc., 40, 2019
5GGU
DownloadVisualize
BU of 5ggu by Molmil
Crystal structure of tremelimumab Fab
Descriptor: heavy chain, light chain
Authors:Heo, Y.S.
Deposit date:2016-06-16
Release date:2016-11-09
Last modified:2016-11-16
Method:X-RAY DIFFRACTION (2.292 Å)
Cite:Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
Nat Commun, 7, 2016
5GGS
DownloadVisualize
BU of 5ggs by Molmil
PD-1 in complex with pembrolizumab Fab
Descriptor: Programmed cell death protein 1, heavy chain, light chain
Authors:Heo, Y.S.
Deposit date:2016-06-16
Release date:2016-11-09
Last modified:2016-11-16
Method:X-RAY DIFFRACTION (1.997 Å)
Cite:Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
Nat Commun, 7, 2016
5GGV
DownloadVisualize
BU of 5ggv by Molmil
CTLA-4 in complex with tremelimumab Fab
Descriptor: Cytotoxic T-lymphocyte protein 4, heavy chain, light chain
Authors:Heo, Y.S.
Deposit date:2016-06-16
Release date:2016-11-09
Last modified:2016-11-16
Method:X-RAY DIFFRACTION (1.998 Å)
Cite:Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
Nat Commun, 7, 2016
5GGT
DownloadVisualize
BU of 5ggt by Molmil
PD-L1 in complex with BMS-936559 Fab
Descriptor: IGK@ protein, IgG H chain, Programmed cell death 1 ligand 1
Authors:Heo, Y.S.
Deposit date:2016-06-16
Release date:2016-11-09
Last modified:2024-03-20
Method:X-RAY DIFFRACTION (2.8 Å)
Cite:Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
Nat Commun, 7, 2016
5GGR
DownloadVisualize
BU of 5ggr by Molmil
PD-1 in complex with nivolumab Fab
Descriptor: Programmed cell death protein 1, heavy chain, light chain
Authors:Heo, Y.S.
Deposit date:2016-06-16
Release date:2016-11-09
Last modified:2016-11-16
Method:X-RAY DIFFRACTION (3.3 Å)
Cite:Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
Nat Commun, 7, 2016
5GGQ
DownloadVisualize
BU of 5ggq by Molmil
Crystal structure of Nivolumab Fab fragment
Descriptor: nivolumab heavy chain, nivolumab light chain
Authors:Heo, Y.S.
Deposit date:2016-06-16
Release date:2016-11-09
Last modified:2016-11-16
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
Nat Commun, 7, 2016
2LCI
DownloadVisualize
BU of 2lci by Molmil
Solution NMR Structure of DE NOVO DESIGNED PROTEIN, P-LOOP NTPASE FOLD, Northeast Structural Genomics Consortium Target OR36 (CASD Target)
Descriptor: Protein OR36
Authors:Liu, G, Koga, N, Koga, R, Xiao, R, Janjua, H, Ciccosanti, C, Lee, H, Acton, T.B, Everett, J, Baker, D, Montelione, G.T, Northeast Structural Genomics Consortium (NESG)
Deposit date:2011-04-29
Release date:2011-06-29
Last modified:2023-06-14
Method:SOLUTION NMR
Cite:Northeast Structural Genomics Consortium Target OR36
To be Published
1F5Y
DownloadVisualize
BU of 1f5y by Molmil
NMR STRUCTURE OF A CONCATEMER OF THE FIRST AND SECOND LIGAND-BINDING MODULES OF THE HUMAN LDL RECEPTOR
Descriptor: CALCIUM ION, LOW-DENSITY LIPOPROTEIN RECEPTOR
Authors:Kurniawan, N.D, Atkins, A.R, Brereton, I.M, Kroon, P.A, Smith, R.
Deposit date:2000-06-18
Release date:2000-08-30
Last modified:2022-02-16
Method:SOLUTION NMR
Cite:NMR structure of a concatemer of the first and second ligand-binding modules of the human low-density lipoprotein receptor.
Protein Sci., 9, 2000
5Y9J
DownloadVisualize
BU of 5y9j by Molmil
BAFF in complex with belimumab
Descriptor: Tumor necrosis factor ligand superfamily member 13B, belibumab light chain, belimumab heavy chain
Authors:Heo, Y.-S, Shin, W.
Deposit date:2017-08-25
Release date:2018-02-21
Last modified:2019-09-04
Method:X-RAY DIFFRACTION (2.05 Å)
Cite:BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus.
Nat Commun, 9, 2018
5Y9K
DownloadVisualize
BU of 5y9k by Molmil
Structure of the belimumab Fab fragment
Descriptor: belimumab heavy chain, belimumab light chain
Authors:Heo, Y.-S, Shin, W.
Deposit date:2017-08-25
Release date:2018-02-21
Last modified:2019-09-04
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus.
Nat Commun, 9, 2018
7WSL
DownloadVisualize
BU of 7wsl by Molmil
PD-1 in complex with Dostarlimab
Descriptor: Programmed cell death protein 1, heavy chain, light chain
Authors:Heo, Y.S.
Deposit date:2022-01-30
Release date:2022-08-24
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (1.534 Å)
Cite:Molecular basis of PD-1 blockade by dostarlimab, the FDA-approved antibody for cancer immunotherapy.
Biochem.Biophys.Res.Commun., 599, 2022

217705

PDB entries from 2024-03-27

PDB statisticsPDBj update infoContact PDBjnumon